Principal Investigator
Lynne I.
Wagner
Awardee Organization
Ecog-Acrin Medical Research Foundation
United States
Fiscal Year
2023
Activity Code
UG1
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date
NIH RePORTER
For more information, see NIH RePORTER Project 3UG1CA189828-10S1
ECOG-ACRIN NCORP Research Base - TMIST
The purpose of the TMSIT study is to compare the propor�ons of par�cipants in the Tomosynthesis (TM) and Digital Mammography (DM) study arms experiencing the occurrence of an “advanced” breast cancer at any �me during a period of 7 years from randomiza�on, including the period of ac�ve screening and a period of follow up a�er the last screen. Supplemental funding includes but is not limited to suppor�ng site reimbursements to non-NCORP sites, core infrastructure, clinical data collec�on, biospecimen collec�on and analysis, imaging collec�on, sta�s�cal analysis, physics quality control program, and central monitoring.
Clinical Trials
Study Name | Clinical Trial ID |
---|---|
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial | NCT06022822 |
Mobile Health for Adherence in Breast Cancer Patients | NCT06112613 |
Comparing Two Methods to Follow Patients With Pancreatic Cysts | NCT04239573 |
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ | NCT02352883 |
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis | NCT04438382 |
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring | NCT04597359 |
Cancer and Blood Pressure Management, CARISMA Study | NCT04467021 |
Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts | NCT02933489 |
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer | NCT04001829 |
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia | NCT03253848 |
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting | NCT03804255 |
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors | NCT06002828 |